$FLGT
Fulgent Genetics, Inc. Stock $flgt

$flgt Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000156459022007366 Filed on February 28, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$251.7M	$227.9M	$992.6M
YoY Change	-14.68%	124.02%	135.37%
Cost Of Revenue	$62.13M	$43.47M	$215.5M
YoY Change	20.01%	65.52%	140.0%
Gross Profit	$189.5M	$184.4M	$777.1M
YoY Change	-22.07%	144.39%	134.12%
Gross Profit Margin	75.31%	80.92%	78.29%
Selling, General & Admin	$30.30M	$18.31M	$75.17M
YoY Change	138.2%	109.15%	149.18%
% of Gross Profit	15.99%	9.93%	9.67%
Research & Development	$7.464M	$6.021M	$24.22M
YoY Change	63.11%	89.52%	109.15%
% of Gross Profit	3.94%	3.27%	3.12%
Depreciation & Amortization	$3.491M	$2.500M	$11.00M
YoY Change	190.92%	246.26%	271.51%
% of Gross Profit	1.84%	1.36%	1.42%
Operating Expenses	$38.68M	$25.13M	$99.39M
YoY Change	123.61%	110.6%	138.08%
Operating Profit	$150.9M	$159.3M	$677.7M
YoY Change	-33.22%	150.73%	133.55%
Interest Expense	-$35.00K	$30.00K	$117.0K
YoY Change	-105.83%		485.0%
% of Operating Profit	-0.02%	0.02%	0.02%
Other Income/Expense, Net
YoY Change
Pretax Income	$150.8M	$159.8M	$677.3M
YoY Change	-33.41%	149.86%	132.2%
Income Tax	$47.15M	$37.55M	$174.8M
% Of Pretax Income	31.26%	23.5%	25.81%
Net Earnings	$104.3M	$122.5M	$507.4M
YoY Change	-37.26%	162.71%	136.74%
Net Earnings / Revenue	41.46%	53.77%	51.12%
Basic Earnings Per Share
Diluted Earnings Per Share	$3.346M	$3.931M	$16.38M
COMMON SHARES
Basic Shares Outstanding		29.67M	29.41M
Diluted Shares Outstanding		31.17M	30.98M

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$450.5M	$470.0M	$450.5M
YoY Change	50.47%	527.48%	50.47%
Cash & Equivalents	$164.9M	$214.9M	$164.9M
Short-Term Investments	$285.6M	$255.1M	$285.6M
Other Short-Term Assets	$22.55M	$32.04M	$16.45M
YoY Change	-44.17%	61.79%	-18.56%
Inventory
Prepaid Expenses	$4.244M	$5.348M
Receivables	$138.9M	$120.8M	$139.1M
Other Receivables	$1.403M	$1.807M	$5.862M
Total Short-Term Assets	$612.0M	$622.8M	$612.0M
YoY Change	16.87%	218.42%	16.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$62.29M	$60.17M	$71.16M
YoY Change	54.95%	199.33%	73.57%
Goodwill	$50.90M	$48.75M
YoY Change
Intangibles	$35.91M
YoY Change
Long-Term Investments	$485.0M	$407.3M	$485.0M
YoY Change	266.07%	1226.66%	266.07%
Other Assets	$10.65M	$21.40M	$23.74M
YoY Change	157.0%	2040.0%	619.36%
Total Long-Term Assets	$666.8M	$581.8M	$666.8M
YoY Change	277.03%	1025.4%	276.91%
TOTAL ASSETS
Total Short-Term Assets	$612.0M	$622.8M	$612.0M
Total Long-Term Assets	$666.8M	$581.8M	$666.8M
Total Assets	$1.279B	$1.205B	$1.279B
YoY Change	82.55%	387.13%	82.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.49M	$24.87M	$20.49M
YoY Change	-22.63%	32.98%	-22.66%
Accrued Expenses	$17.69M	$10.68M	$17.69M
YoY Change	109.44%	77.95%	103.32%
Deferred Revenue	$14.57M	$7.900M
YoY Change	-45.18%
Short-Term Debt	$21.28M	$15.11M	$21.28M
YoY Change	41.89%		41.89%
Long-Term Debt Due	$332.0K	$16.00K	$332.0K
YoY Change
Total Short-Term Liabilities	$105.3M	$147.2M	$105.3M
YoY Change	-19.06%	155.04%	-19.05%
LONG-TERM LIABILITIES
Long-Term Debt	$1.398M	$5.978M	$1.398M
YoY Change
Other Long-Term Liabilities	$6.805M	$6.545M	$5.407M
YoY Change	1069.24%	197.5%	801.17%
Total Long-Term Liabilities	$6.805M	$12.52M	$6.805M
YoY Change	1069.24%	469.23%	1034.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$105.3M	$147.2M	$105.3M
Total Long-Term Liabilities	$6.805M	$12.52M	$6.805M
Total Liabilities	$112.8M	$167.9M	$120.0M
YoY Change	-13.91%	177.96%	-8.49%
SHAREHOLDERS EQUITY
Retained Earnings	$657.6M
YoY Change	335.84%
Common Stock	$501.9M
YoY Change	20.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.159B	$1.037B	$1.159B
YoY Change
Total Liabilities & Shareholders Equity	$1.279B	$1.205B	$1.279B
YoY Change	82.55%	387.13%	82.54%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	$104.3M	$122.5M	$507.4M
YoY Change	-37.26%	162.71%	136.74%
Depreciation, Depletion And Amortization	$3.491M	$2.500M	$11.00M
YoY Change	190.92%	246.26%	271.51%
Cash From Operating Activities	$77.09M	$152.2M	$538.6M
YoY Change	-42.56%	1519.16%	282.98%
INVESTING ACTIVITIES
Capital Expenditures	-$6.015M	-$3.402M	$23.81M
YoY Change	-74.73%	-66.32%	-32.22%
Acquisitions			$61.87M
YoY Change
Other Investing Activities	-$134.2M	-$31.39M	-$522.7M
YoY Change	-54.49%	-456.72%	79.44%
Cash From Investing Activities	-$140.3M	-$34.79M	-$546.5M
YoY Change	-55.99%	2385.21%	67.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$89.48M
YoY Change			-136.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.15M	-2.989M	85.41M
YoY Change	-93.99%	-107.03%	-67.31%
NET CHANGE
Cash From Operating Activities	77.09M	152.2M	538.6M
Cash From Investing Activities	-140.3M	-34.79M	-546.5M
Cash From Financing Activities	13.15M	-2.989M	85.41M
Net Change In Cash	-50.02M	114.4M	77.47M
YoY Change	-244.98%	126.57%	2.66%
FREE CASH FLOW
Cash From Operating Activities	$77.09M	$152.2M	$538.6M
Capital Expenditures	-$6.015M	-$3.402M	$23.81M
Free Cash Flow	$83.10M	$155.6M	$514.8M
YoY Change	-47.4%	697.96%	387.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Revenue Practical Expedient Remaining Performance Obligation RevenuePracticalExpedientRemainingPerformanceObligation	true
CY2021	us-gaap	Preferred Stock Redemption Date PreferredStockRedemptionDate	2027-07-31
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	4978 Santa Anita Avenue
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Entity File Number EntityFileNumber	001-37894
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-2621304
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Temple City
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91780
CY2021	dei	City Area Code CityAreaCode	626
CY2021	dei	Local Phone Number LocalPhoneNumber	350-0537
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	1600000000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30252511
CY2021	dei	Auditor Firm AuditorFirmId	34
CY2021	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2021	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164894000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87426000
CY2021Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Current AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesCurrent	285605000
CY2020Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Current AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesCurrent	211941000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11217000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1898000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	138912000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	183857000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	22549000
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40392000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	611960000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	523616000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	485047000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	132502000
CY2021Q4	flgt	Redeemable Preferred Stock Investment Noncurrent RedeemablePreferredStockInvestmentNoncurrent	21965000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40199000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	35914000
CY2021Q4	us-gaap	Goodwill Goodwill	50897000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10650000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4144000
CY2021Q4	us-gaap	Assets Assets	1278720000
CY2020Q4	us-gaap	Assets Assets	700461000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20494000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	26488000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17689000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8446000
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	787000
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	53319000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14570000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	26576000
CY2021Q4	flgt	Customer Deposit CustomerDeposit	19806000
CY2020Q4	flgt	Customer Deposit CustomerDeposit	185000
CY2021Q4	flgt	Investment Margin Liabilities Current InvestmentMarginLiabilitiesCurrent	15137000
CY2020Q4	flgt	Investment Margin Liabilities Current InvestmentMarginLiabilitiesCurrent	15019000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	10000000
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	6147000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	680000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	82000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	105310000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	130115000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	725000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	377000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6805000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	582000
CY2021Q4	us-gaap	Liabilities Liabilities	112840000
CY2020Q4	us-gaap	Liabilities Liabilities	131074000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30160000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30160000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28178000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28178000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	3000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	501908000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	418065000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-759000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	438000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	657597000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	150881000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1158749000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	569387000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	7131000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1165880000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	569387000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1278720000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	700461000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	992584000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	421712000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32528000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	215533000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	89807000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	14107000
CY2021	us-gaap	Gross Profit GrossProfit	777051000
CY2020	us-gaap	Gross Profit GrossProfit	331905000
CY2019	us-gaap	Gross Profit GrossProfit	18421000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24219000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11580000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6537000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24439000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14952000
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5898000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50732000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15215000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6414000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1708000
CY2019	us-gaap	Operating Expenses OperatingExpenses	18849000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	677300000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	291684000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	409000
CY2021	flgt	Income Loss Before Equity Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityLossInInvesteeAndGainLossOnEquityMethodInvestments	502505000
CY2020	flgt	Income Loss Before Equity Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityLossInInvesteeAndGainLossOnEquityMethodInvestments	219152000
CY2019	flgt	Income Loss Before Equity Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityLossInInvesteeAndGainLossOnEquityMethodInvestments	366000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-488000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-777000
CY2021	flgt	Gain Loss On Equity Method Investments GainLossOnEquityMethodInvestments	3734000
CY2020	flgt	Gain Loss On Equity Method Investments GainLossOnEquityMethodInvestments	-4354000
CY2021	us-gaap	Profit Loss ProfitLoss	506239000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1125000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	507364000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	214310000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-411000
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	17.25
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	9.44
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.02
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	16.38
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	8.91
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.02
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22694000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18709000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18709000
CY2021	us-gaap	Profit Loss ProfitLoss	506239000
CY2020	us-gaap	Profit Loss ProfitLoss	214310000
CY2019	us-gaap	Profit Loss ProfitLoss	-411000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	456000
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	20000
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-17000
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	272000
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	198000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	505147000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	214602000
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-230000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1125000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	105000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1020000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	506167000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	214602000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-230000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	51152000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3209000
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	38000
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	21000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	181000
CY2019	us-gaap	Profit Loss ProfitLoss	-411000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	82777000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8157000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	104000
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	62000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	292000
CY2020	us-gaap	Profit Loss ProfitLoss	214310000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	569387000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15882000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	86000
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4155000
CY2021	us-gaap	Income Tax Effects Allocated Directly To Equity Cumulative Effect Of Change In Accounting Principle IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple	239000
CY2021	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	8151000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1092000
CY2021	us-gaap	Profit Loss ProfitLoss	506239000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1165880000
CY2021	us-gaap	Profit Loss ProfitLoss	506239000
CY2020	us-gaap	Profit Loss ProfitLoss	214310000
CY2019	us-gaap	Profit Loss ProfitLoss	-411000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	15882000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	8157000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3209000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11004000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2962000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2107000
CY2021	flgt	Noncash Lease Expense NoncashLeaseExpense	1154000
CY2020	flgt	Noncash Lease Expense NoncashLeaseExpense	409000
CY2019	flgt	Noncash Lease Expense NoncashLeaseExpense	413000
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-850000
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-672000
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-11000
CY2021	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	7596000
CY2020	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	857000
CY2019	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	106000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8931000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1170000
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	189000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8188000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1775000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21000
CY2021	flgt	Unrecognized Tax Benefits Operating Activities UnrecognizedTaxBenefitsOperatingActivities	-348000
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1186000
CY2020	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-90000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-488000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-777000
CY2021	flgt	Gain Loss On Equity Method Investment GainLossOnEquityMethodInvestment	3734000
CY2020	flgt	Gain Loss On Equity Method Investment GainLossOnEquityMethodInvestment	-4354000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	15000
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-8000
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-52000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-42300000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	178480000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	839000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7804000
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	21149000
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-374000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12206000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	22617000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-329000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	13081000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	32655000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	264000
CY2021	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-52532000
CY2020	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	53295000
CY2019	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	24000
CY2021	flgt	Increase Decrease In Operating And Finance Lease Liabilities IncreaseDecreaseInOperatingAndFinanceLeaseLiabilities	-1123000
CY2020	flgt	Increase Decrease In Operating And Finance Lease Liabilities IncreaseDecreaseInOperatingAndFinanceLeaseLiabilities	-389000
CY2019	flgt	Increase Decrease In Operating And Finance Lease Liabilities IncreaseDecreaseInOperatingAndFinanceLeaseLiabilities	-409000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	538577000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	140628000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5517000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23812000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35130000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1182000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	32000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	63000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	710490000
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	324359000
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	52077000
CY2021	flgt	Payment For Purchase Of Redeemable Preferred Stock PaymentForPurchaseOfRedeemablePreferredStock	20000000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	83842000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	19919000
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	24350000
CY2021	flgt	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	185749000
CY2020	flgt	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	17095000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	61868000
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3971000
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	137000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-546548000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-326438000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29046000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	89475000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	246190000
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	28758000
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	10000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	86000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	104000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	38000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4155000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	62000
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	21000
CY2021	flgt	Repayment Of Notes Payable RepaymentOfNotesPayable	4000
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	15019000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	85405000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	261251000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28775000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20000
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-17000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	77468000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	75461000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5229000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87426000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11965000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6736000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	164894000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87426000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11965000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	237069000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	20612000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	20000
CY2021	flgt	Noncash Or Part Noncash Contingent Consideration For Business Acquisition Included In Current Liabilities NoncashOrPartNoncashContingentConsiderationForBusinessAcquisitionIncludedInCurrentLiabilities	10000000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1075000
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	3402000
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	557000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1797000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	402000
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	110000
CY2021	flgt	Operating Lease Right Of Use Assets Reduced Due To Lease Modification And Termination OperatingLeaseRightOfUseAssetsReducedDueToLeaseModificationAndTermination	399000
CY2020	flgt	Operating Lease Right Of Use Assets Reduced Due To Lease Modification And Termination OperatingLeaseRightOfUseAssetsReducedDueToLeaseModificationAndTermination	1853000
CY2020	flgt	Noncash Or Part Noncash Public Offering Proceeds In Other Receivable Included In Other Current Assets NoncashOrPartNoncashPublicOfferingProceedsInOtherReceivableIncludedInOtherCurrentAssets	17799000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1693000
CY2021	flgt	Noncash Or Part Noncash Public Offering Costs Included In Accounts Payable NoncashOrPartNoncashPublicOfferingCostsIncludedInAccountsPayable	5000
CY2020	flgt	Noncash Or Part Noncash Public Offering Costs Included In Accounts Payable NoncashOrPartNoncashPublicOfferingCostsIncludedInAccountsPayable	359000
CY2019	flgt	Noncash Or Part Noncash Public Offering Costs Included In Accounts Payable NoncashOrPartNoncashPublicOfferingCostsIncludedInAccountsPayable	129000
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.15%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting periods. These estimates, judgments and assumptions are based on historical data and experience available at the date of the accompanying consolidated financial statements, as well as various other factors management believes to be reasonable under the circumstances, including but not limited to the potential impacts arising from the recent global pandemic related to COVID-19. As the extent and duration of the impacts from COVID-19 remain unclear, the Company’s estimates and assumptions may evolve as conditions change. Actual results could differ significantly from these estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.15%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an on-going basis, management evaluates its estimates, primarily those related to: <span style="color:#000000;">(i) revenue recognition criteria, (ii) accounts receivable and allowances for credit losses, (iii) the useful lives of fixed assets and intangible assets, (iv) estimates of tax liabilities, and (v) valuation of intangible </span>assets<span style="color:#000000;"> and goodwill.</span></p>
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1898000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	751000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	590000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8931000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1170000
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	189000
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	499000
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	23000
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	28000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11217000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1898000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	751000
CY2021Q4	flgt	Redeemable Preferred Stock Investment Noncurrent RedeemablePreferredStockInvestmentNoncurrent	22000000.0
CY2021	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	2000000.0
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk, Customers and Suppliers</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade accounts receivable and marketable securities, which consist of debt securities and equity securities. As of December 31, 2021, substantially all of the Company’s cash and cash equivalents were deposited in accounts at financial institutions, </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and amounts may exceed federally insured limits. Management believes that the Company is not exposed to significant credit risk due to the financial strength of the depository institutions in which its cash and cash equivalents are held.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain periods, a small number of customers has accounted for a significant portion of the Company’s revenue. Aggregating customers under common control, one customer comprised 26% of total revenue in the year ended December 31, 2021, two customers comprised 28% and 10% of total revenue in the year ended December 31, 2020, <span style="color:#000000;">and one customer comprised 28% of total revenue in the year ended December 31, 2019.</span> No customer comprised at least 10% of total accounts receivable as of December 31, 2021 and 2020.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company relies on a limited number of suppliers for its test collection kits and certain laboratory substances used in the chemical reactions incorporated into its processes, referred to as reagents, as well as for the sequencers and various other equipment and materials it uses in its laboratory operations. In particular, the Company relies on a sole supplier for the next generation sequencers and associated reagents it uses to perform its genetic tests and as the sole provider of maintenance and repair services for these sequencers. The Company’s laboratory operations would be interrupted if it encountered delays or difficulties securing these test collection kits, reagents, sequencers, other equipment or materials or maintenance and repair services, which could occur for a variety of reasons, including if the Company needs a replacement or temporary substitute for any of its limited or sole suppliers and is not able to locate and make arrangements with an acceptable replacement or temporary substitute. The Company believes there are currently only a few other manufacturers that are capable of supplying and servicing some of the equipment and other materials necessary for its laboratory operations, including collection kits, sequencers and various associated reagents. </p>
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2021	flgt	Number Of Customer Types NumberOfCustomerTypes	3
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	456000
CY2021	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	437000
CY2020	flgt	Tax Effects Related To Unrealized Holding Gains On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingGainsOnAvailableForSaleDebtSecurities	147000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	26400000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	257000
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	59000
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	77067000
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	77067000
CY2021Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Amortized Cost Basis AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesAmortizedCostBasis	794892000
CY2021Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Gain Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedGainBeforeTax	2038000
CY2021Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Loss Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedLossBeforeTax	4313000
CY2021Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecurities	792617000
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	47461000
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	47461000
CY2020Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Amortized Cost Basis AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesAmortizedCostBasis	343987000
CY2020Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Gain Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedGainBeforeTax	754000
CY2020Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Loss Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedLossBeforeTax	298000
CY2020Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecurities	344443000
CY2021	flgt	Available For Sale Debt Securities And Equity Trading Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesAndEquityTradingSecuritiesGrossUnrealizedLoss	4300000
CY2020	flgt	Available For Sale Debt Securities And Equity Trading Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesAndEquityTradingSecuritiesGrossUnrealizedLoss	298000
CY2021Q4	flgt	Fair Value Assets Transfers Between Levels Amount FairValueAssetsTransfersBetweenLevelsAmount	0
CY2020Q4	flgt	Fair Value Assets Transfers Between Levels Amount FairValueAssetsTransfersBetweenLevelsAmount	0
CY2019Q4	flgt	Fair Value Assets Transfers Between Levels Amount FairValueAssetsTransfersBetweenLevelsAmount	0
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	81917000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	51119000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19630000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10920000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62287000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40199000
CY2021	us-gaap	Depreciation Depreciation	9300000
CY2020	us-gaap	Depreciation Depreciation	3000000.0
CY2019	us-gaap	Depreciation Depreciation	2100000
CY2021Q4	flgt	Reagents And Supplies Current ReagentsAndSuppliesCurrent	12206000
CY2020Q4	flgt	Reagents And Supplies Current ReagentsAndSuppliesCurrent	16491000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4244000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3682000
CY2021Q4	flgt	Marketable Securities Interest Receivable Current MarketableSecuritiesInterestReceivableCurrent	2743000
CY2020Q4	flgt	Marketable Securities Interest Receivable Current MarketableSecuritiesInterestReceivableCurrent	1016000
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1716000
CY2020Q4	us-gaap	Prepaid Taxes PrepaidTaxes	14000
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1403000
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	17810000
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	237000
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1379000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	22549000
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40392000
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2021	flgt	Operating Leases Term Of Expiration OperatingLeasesTermOfExpiration	2028-03
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32528000
CY2021	flgt	Debt Security Investment Outstanding Borrowing Amount DebtSecurityInvestmentOutstandingBorrowingAmount	15100000
CY2021	flgt	Debt Instrument Interest Rate At Beginning Of Period DebtInstrumentInterestRateAtBeginningOfPeriod	0.01
CY2021	flgt	Debt Instrument Interest Rate At End Of Period DebtInstrumentInterestRateAtEndOfPeriod	0.01
CY2021	us-gaap	Interest Expense InterestExpense	117000
CY2020	us-gaap	Interest Expense InterestExpense	20000
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	11600000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	10000000.0
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	992584000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	421712000
CY2021Q1	flgt	Lessee Operating Lease Extended Lease Term Expiration Date LesseeOperatingLeaseExtendedLeaseTermExpirationDate	2023-01-31
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7141000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	828000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1842000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	267000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5344000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	568000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1735000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	332000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1398000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	366000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1080000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7782000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1262000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	566000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	587000
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	7000
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	296000
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	142000
CY2021	us-gaap	Lease Cost LeaseCost	1566000
CY2020	us-gaap	Lease Cost LeaseCost	708000
CY2019	us-gaap	Lease Cost LeaseCost	587000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y11M15D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0315
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y11M8D
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0321
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2037000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	383000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1579000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	383000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1154000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	376000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1048000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	366000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	884000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1874000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	596000
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	144000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7186000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1730000
CY2021	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	413000
CY2020	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	144000
CY2021	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	7000
CY2020	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	1000
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	420000
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	145000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	355000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	264000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	180000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	120000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	919000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15882000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8157000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3209000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	174795000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	72532000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0599
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	681403000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	291739000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	679000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4103000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-55000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-270000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	677300000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	291684000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	409000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	131907000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	53794000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	51076000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	20513000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	38000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	182983000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	74307000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	43000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7471000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-248000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-249000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-717000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-14000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-280000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	669000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	669000
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1513000
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-529000
CY2021	flgt	Deferred Income Tax Expense Benefit Including Of Change In Valuation Allowance DeferredIncomeTaxExpenseBenefitIncludingOfChangeInValuationAllowance	-8188000
CY2020	flgt	Deferred Income Tax Expense Benefit Including Of Change In Valuation Allowance DeferredIncomeTaxExpenseBenefitIncludingOfChangeInValuationAllowance	-1775000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0568
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2021000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2125000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	19311000
CY2021Q4	flgt	Deferred Tax Assets Foreign Taxes DeferredTaxAssetsForeignTaxes	1808000
CY2020Q4	flgt	Deferred Tax Assets Foreign Taxes DeferredTaxAssetsForeignTaxes	1220000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.4676
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.1383
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0005
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0013
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0196
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0092
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.5353
CY2021	flgt	Effective Income Tax Rate Reconciliation Return To Provision EffectiveIncomeTaxRateReconciliationReturnToProvision	-0.0017
CY2020	flgt	Effective Income Tax Rate Reconciliation Return To Provision EffectiveIncomeTaxRateReconciliationReturnToProvision	-0.0011
CY2019	flgt	Effective Income Tax Rate Reconciliation Return To Provision EffectiveIncomeTaxRateReconciliationReturnToProvision	-0.5711
CY2021	flgt	Effective Income Tax Rate Reconciliation Other Permanent Differences EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences	0.0109
CY2020	flgt	Effective Income Tax Rate Reconciliation Other Permanent Differences EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences	0.0002
CY2019	flgt	Effective Income Tax Rate Reconciliation Other Permanent Differences EffectiveIncomeTaxRateReconciliationOtherPermanentDifferences	0.0387
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0014
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0041
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0010
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0052
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1.2922
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2576
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2487
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1053
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1486000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	166000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	97000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2755000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	513000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	180000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	199000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	206000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	445000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1739000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1424000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	609000
CY2021Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	10991000
CY2020Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	4306000
CY2019Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	8000
CY2019Q4	flgt	Deferred Tax Assets Foreign Taxes DeferredTaxAssetsForeignTaxes	545000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	680000
CY2021Q4	flgt	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	1643000
CY2020Q4	flgt	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	226000
CY2019Q4	flgt	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	643000
CY2021Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	700000
CY2020Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	700000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	599000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	89000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21920000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8850000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3207000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2609000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6829000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1082000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	8083000
CY2021Q4	flgt	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	7371000
CY2020Q4	flgt	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	4830000
CY2019Q4	flgt	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	419000
CY2021Q4	flgt	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1640000
CY2020Q4	flgt	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	224000
CY2019Q4	flgt	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	633000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1458000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	147000
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	30000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	18552000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5201000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1082000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	759000
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1628000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2600000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2000000.0
CY2020Q4	flgt	Unrecognized Tax Benefits Excluding Interest Liability UnrecognizedTaxBenefitsExcludingInterestLiability	377000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	141000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	333000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	236000
CY2021Q4	flgt	Unrecognized Tax Benefits Excluding Interest Liability UnrecognizedTaxBenefitsExcludingInterestLiability	710000
CY2020Q4	flgt	Unrecognized Tax Benefits Excluding Interest Liability UnrecognizedTaxBenefitsExcludingInterestLiability	377000
CY2021Q4	flgt	Unrecognized Tax Benefits Excluding Interest Liability UnrecognizedTaxBenefitsExcludingInterestLiability	710000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	710000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	15000
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	15000
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2021	us-gaap	Net Income Loss NetIncomeLoss	507364000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	214310000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-411000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29408000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22694000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18709000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30976000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24056000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18709000
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	17.25
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	9.44
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.02
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	16.38
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	8.91
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.02
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	697000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	422000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	237000
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	24022000
CY2021	flgt	Business Acquisitions Pro Forma Operating Income Loss BusinessAcquisitionsProFormaOperatingIncomeLoss	-2756000
CY2021Q4	us-gaap	Goodwill Goodwill	50897000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	35914000
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	251671000
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	227868000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	153616000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	359429000
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	294978000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	101716000
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17265000
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7753000
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue	62134000
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	43466000
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	35858000
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	74075000
CY2020Q4	us-gaap	Cost Of Revenue CostOfRevenue	51772000
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	26261000
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	7717000
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	4057000
CY2021Q4	us-gaap	Gross Profit GrossProfit	189537000
CY2021Q3	us-gaap	Gross Profit GrossProfit	184402000
CY2021Q2	us-gaap	Gross Profit GrossProfit	117758000
CY2021Q1	us-gaap	Gross Profit GrossProfit	285354000
CY2020Q4	us-gaap	Gross Profit GrossProfit	243206000
CY2020Q3	us-gaap	Gross Profit GrossProfit	75455000
CY2020Q2	us-gaap	Gross Profit GrossProfit	9548000
CY2020Q1	us-gaap	Gross Profit GrossProfit	3696000
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7464000
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6021000
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5312000
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5422000
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4576000
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3177000
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1849000
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1978000
CY2021Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8200000
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6012000
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5219000
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5008000
CY2020Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5081000
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5014000
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3260000
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1597000
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22102000
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12299000
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8329000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8002000
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7640000
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3741000
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1799000
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2035000
CY2021Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	911000
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	797000
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	38677000
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	25129000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	18860000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	18432000
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	17297000
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	11932000
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	6908000
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	5610000
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	150860000
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	159273000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	98898000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	266922000
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	225909000
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	63523000
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2640000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1914000
CY2021Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-35000
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	496000
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	604000
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	282000
CY2020Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	589000
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	421000
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	275000
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	241000
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	150825000
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	159769000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99502000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	267204000
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	226498000
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	63944000
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2915000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1673000
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47148000
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37545000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23589000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	66513000
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58571000
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.34
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14526000
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-599000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34000
CY2021Q4	flgt	Income Loss Before Equity Earnings Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityEarningsLossInInvesteeAndGainLossOnEquityMethodInvestments	103677000
CY2021Q3	flgt	Income Loss Before Equity Earnings Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityEarningsLossInInvesteeAndGainLossOnEquityMethodInvestments	122224000
CY2021Q2	flgt	Income Loss Before Equity Earnings Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityEarningsLossInInvesteeAndGainLossOnEquityMethodInvestments	75913000
CY2021Q1	flgt	Income Loss Before Equity Earnings Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityEarningsLossInInvesteeAndGainLossOnEquityMethodInvestments	200691000
CY2020Q4	flgt	Income Loss Before Equity Earnings Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityEarningsLossInInvesteeAndGainLossOnEquityMethodInvestments	167927000
CY2020Q3	flgt	Income Loss Before Equity Earnings Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityEarningsLossInInvesteeAndGainLossOnEquityMethodInvestments	49418000
CY2020Q2	flgt	Income Loss Before Equity Earnings Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityEarningsLossInInvesteeAndGainLossOnEquityMethodInvestments	3514000
CY2020Q1	flgt	Income Loss Before Equity Earnings Loss In Investee And Gain Loss On Equity Method Investments IncomeLossBeforeEquityEarningsLossInInvesteeAndGainLossOnEquityMethodInvestments	-1707000
CY2020Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	143000
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-189000
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-193000
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-249000
CY2021Q2	flgt	Gain Loss On Equity Method Investments GainLossOnEquityMethodInvestments	3734000
CY2020Q4	flgt	Gain Loss On Equity Method Investments GainLossOnEquityMethodInvestments	-1763000
CY2020Q3	flgt	Gain Loss On Equity Method Investments GainLossOnEquityMethodInvestments	-2591000
CY2021Q4	us-gaap	Profit Loss ProfitLoss	103677000
CY2021Q3	us-gaap	Profit Loss ProfitLoss	122224000
CY2021Q2	us-gaap	Profit Loss ProfitLoss	79647000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	200691000
CY2020Q4	us-gaap	Profit Loss ProfitLoss	166307000
CY2020Q3	us-gaap	Profit Loss ProfitLoss	46638000
CY2020Q2	us-gaap	Profit Loss ProfitLoss	3321000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-1956000
CY2021Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-662000
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-298000
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-165000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	104339000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	122522000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	79812000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	200691000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	166307000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	46638000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	3321000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-1956000
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.48
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.13
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.74
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	6.96
CY2020Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	6.55
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.11
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.15
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.93
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.59
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	6.52
CY2020Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	6.16
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.98
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.14
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09

Files In Submission

Name	View Source	Status
0001564590-22-007366-index-headers.html	Edgar Link	pending
0001564590-22-007366-index.html	Edgar Link	pending
0001564590-22-007366.txt	Edgar Link	pending
0001564590-22-007366-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
flgt-10k_20211231.htm	Edgar Link	pending
flgt-10k_20211231_htm.xml	Edgar Link	completed
flgt-20211231.xsd	Edgar Link	pending
flgt-20211231_cal.xml	Edgar Link	unprocessable
flgt-20211231_def.xml	Edgar Link	unprocessable
flgt-20211231_lab.xml	Edgar Link	unprocessable
flgt-20211231_pre.xml	Edgar Link	unprocessable
flgt-ex1041_29.htm	Edgar Link	pending
flgt-ex211_7.htm	Edgar Link	pending
flgt-ex231_6.htm	Edgar Link	pending
flgt-ex311_9.htm	Edgar Link	pending
flgt-ex312_10.htm	Edgar Link	pending
flgt-ex321_8.htm	Edgar Link	pending
gmqarqv1zcun000001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FLGT
Fulgent Genetics, Inc. Stock $flgt

2021 Q4 Form 10-K Financial Statement

#000156459022007366 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLGT Fulgent Genetics, Inc. Stock $flgt

2021 Q4 Form 10-K Financial Statement

#000156459022007366 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLGT
Fulgent Genetics, Inc. Stock $flgt